RNU6-917P

Across TCGA pan-cancer cohorts, RNU6-917P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-917P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU6-917P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-917P expression acts as an unfavorable survival marker, although some lineages such as SKCM and BRCA show a favorable association.

SKCM, BRCA, and ACC are the cancer types where RNU6-917P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.723	0.572	<.001	84	view →
BRCA	DFS	Tertile	All	0.939	0.890	.006	78	view →
ACC	OS	Tertile	III,IV	0.247	0.789	<.001	72	view →
CESC	DFS	Tertile	All	0.870	0.702	.004	60	view →
READ	OS	Tertile	III,IV	0.277	0.885	<.001	33	view →
HNSC	DFS	Tertile	III,IV	0.691	0.536	.008	30	view →
THYM	OS	Tertile	All	0.877	0.993	.016	21	view →
KIRC	OS	Quartile	All	0.511	0.655	.004	17	view →
BLCA	DFS	Tertile	III,IV	0.224	0.402	.020	15	view →
STAD	DFS	Tertile	IV	0.835	0.294	.037	12	view →
UVM	DFS	Tertile	All	0.776	0.340	.043	12	view →
UCS	DFS	Tertile	All	0.658	0.221	.039	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-917P–SKCM (DFS)

Open the SKCM breakdown →